OncBioMune Research Shows Activity of PGT Technology in a Mammary Cancer Animal Model Life Science Investing
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT™ for Migraines with Grupo JUSTE in Spain and Additional Potential Territories Life Science Investing
Intercept Pharmaceuticals Announces Pricing of Public Offering of Convertible Senior Notes Life Science Investing
Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy Life Science Investing
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD) Life Science Investing
Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction Life Science Investing
RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn's Disease Associated with MAP Infection Life Science Investing
Predictive Technology Group, Inc. (PRED) Announces Key Patent Issuance by US Patent and Trademark Office for Treating Patients With Genetic Spinal Deformities and Syndromes Life Science Investing
SCYNEXIS Announces Pricing of $22.5 Million Public Offering of Common Stock and Warrants Life Science Investing
